Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale

Journal of Psychopharmacology

Volumn 24, Issue 1, 2010, Pages 111-120

  Montejo, A L ^a   Prieto, N ^a   Terleira, A ^b   Matias, J ^a   Alonso, S ^a   Paniagua, G ^b   Naval, S ^a   Parra, D G ^b   Gabriel, C ^c   Mocaer E ^c   Portoles A ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Agomelatine; Antidepressant; PRSexDQ; Salsex; Scales; Sexual dysfunction; SSRIs

Indexed keywords

AGOMELATINE; PAROXETINE; PLACEBO;

ADULT; ANORGASMIA; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; EJACULATION; EJACULATION DISORDER; ERECTILE DYSFUNCTION; EVENING DOSAGE; HEADACHE; HUMAN; HUMAN EXPERIMENT; LIBIDO DISORDER; MALE; MORNING DOSAGE; NAUSEA; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOTROPIC RELATED SEXUAL DYSFUNCTION SALAMANCA SEX QUESTIONNAIRE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SOMNOLENCE;

ACETAMIDES; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PAROXETINE; PSYCHOMETRICS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TIME FACTORS; YOUNG ADULT;

EID: 76249132673     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108096507     Document Type: Article

References (44)

1. Ahl, J., Kinon, BJ, Liu-Seifert, H. (2004) Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels. Ann N Y Acad Sci 1032: 289-290.
2. Bhasin, S., Enzlin, P., Coviello, A., Basson, R. (2007) Sexual dysfunction in men and women with endocrine disorders. Lancet 369: 597-611.
3. Clayton, A., Kornstein, S., Prakash, A., Mallinckrodt, C., Wohlreich, M. (2007) Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 4: 917-929. (Pubitemid 47082256)
4. Clayton, AH, Montejo, AL (2006) Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry 67 (Suppl. 6). 33-37.
5. Clayton, AH, Pradko, JF, Croft, HA, Montano, CB, Leadbetter, RA, Bolden-Watson, C., et al. (2002) Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 63: 357-366.
6. Compton, MT, Miller, AH (2002) Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol Bull 36: 143-164.
7. Cowen, PJ, Sargent, PA (1997) Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neuro-transmission. J Psychopharmacol 11: 345-348.
8. Delgado, PL, Brannan, SK, Mallinckrodt, CH, Tran, PV, McNamara, RK, Wang, F., et al. (2005) Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 66: 686-692.
9. Kasper, S., Laigle, L., Baylé, F. (2008) Superior antidepressant efficacy of agomelatine vs sertraline: a randomised, double-blind study. J Clin Psychopharmacol 28: 329-333.
10. Kennedy, SH (2005) Sexual function in remitted depressed patients following agomelatine and venlafaxine XR treatment. Eur Neuropsychopharmacol 15: S440.
11. Kennedy, SH (2007) Agomelatine: an antidepressant with a novel mechanism of action. Future Neurol 2: 145-151.
12. Kennedy, SH, Emsley, R. (2006) Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol 16: 93-100.
13. Kennedy, SH, Fulton, KA, Bagby, RM, Greene, AL, Cohen, NL, Rafi, TS (2006) Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry 51: 42.
14. Kennedy, SH, Ralevski, E., Davis, C., Neitzert, C. (1996) The effects of moclobemide on sexual desire and function in healthy volunteers. Eur Neuropsychopharmacol 6: 177-181.
15. Kennedy, SH, Rizvi, S., Fulton, K., Rasmussen, J. (2008) A double-blind comparison of sexual functioning, antidepressant efficacy and tolerability between agomelatine and venlafaxine-XR. J Clin Psychopharmacol (in press).
16. Lemoine, P., Guilleminault, C., Alvarez, E. (2007) Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. J Clin Psychiatry 68: 1723-1732. (Pubitemid 350247502)
17. Loo, H., Hale, A. D̈haenen, H. (2002) Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol 17: 239-247.
18. Ludovico, GM, Corvasce, A., Pagliarulo, G., Cirillo-Marucco, E., Marano, A., Pagliarulo, A. (1996) Paroxetine in the treatment of premature ejaculation. Br J Urol 77: 881-882.
19. McGahuey, CA, Gelenberg, AJ, Laukes, CA, Moreno, FA, Delgado, PL, McKnight, KM, et al. (2000) The Arizona Sexual Experience Scale (ASEX). reliability and validity. J Sex Marital Ther 26: 25-40.
20. Montejo, AI, Llorca, G., Izquierdo, JA, Ledesma, A., Bousono, M., Calcedo, A., et al. (1996) Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients. Actas Luso Esp Neurol Psiquiatr Cienc Afines 24: 311-321.
21. Montejo, AL, Garcia, M., Espada, M., Rico-Villademoros, F., Llorca, G., Izquierdo, JA (2000) Psychometric characteristics of the Psychotropic-Related Sexual Dysfunction Questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions. Actas Esp Psiquiatr 28: 141-150.
22. Montejo, AL, Rico-Villademoros, F. (2008) Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J SEX & Marital Therapy 34: 227-239.
23. Montejo, AL, Llorca, G., Izquierdo, JA (1997) SSRI-induced sexual dysfunction. Fluoxetine, paroxetine, sertraline and fluvoxamine in a prospective, multi-center and descriptive clinical study of 344 patients. J Sex Marital Ther 23: 176-184.
24. Montejo, AL, Llorca, G., Izquierdo, JA (1999) Sexual Dysfunction with antidepressive agents. Effect of the change to Amineptine in patients with sexual dysfunction secondary to SSRI. Actas Españolas de Psiquiatría 27: 23-34.
25. Montejo, AL, Llorca, G., Izquierdo, JA, Rico-Villademoros, F. (2001) Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish working group for the study of psychotropic-related sexual dysfunction. J Clin Psychiatry 62 (Suppl. 3). 10-21.
26. Nafziger, AN, Bertino, JS, Goss-Bley, AI, Kashuba, AD (1999) Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy. J Clin Psychiatry 60: 187-190.
27. Olié, JP, Kasper, S. (2007) Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol 10: 661-673.
28. Roose, SP (1999) Tolerability and patient compliance. J Clin Psychiatry 60 (Suppl. 17). 14-17.
29. Rosen, RC, Lane, RM, Menza, M. (1999) Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 19: 67-85.
30. Rosen, RC, Riley, A., Wagner, G., Osterloh, IH, Kirkpatrick, J., Mishra, A. (1997) The international index of erectile function (IIEF). a multidimensional scale for assessment of erectile dysfunction. Urology 49: 822-830.
31. Rothschild, AJ (2000) Sexual side effects of antidepressants. J Clin Psychiatry 61 (Suppl. 11). 28-36.
32. Salonia, A., Maga, T., Colombo, R., Scattoni, V., Briganti, A., Cestari, A., et al. (2002) A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 168: 2486-2489.
33. Schlosser, R., Wetzel, H., Dorr, H., Rossbach, W., Hiemke, C., Benkert, O. (2000) Effects of subchronic paroxetine administration on nighttime endocrinological profiles in healthy male volunteers. Psychoneuroendocrinology 25: 377-388.
34. Smith, SM, öKeane, V., Murray, R. (2002) Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 181: 49-55.
35. Waldinger, MD (2007) Premature ejaculation: definition and drug treatment. Drugs 67: 547-568.
36. Waldinger, MD, Hengeveld, MW, Zwinderman, AH (1994) Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 151: 1377-1379.
37. Waldinger, MD, Hengeveld, MW, Zwinderman, AH (1997) Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br J Urol 79: 592-595.
38. Waldinger, MD, Hengeveld, MW, Zwinderman, AH, Olivier, B. (1998) Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 18: 274-281.
39. Waldinger, MD, Olivier, B. (2004) Utility of selective serotonin reuptake inhibitors in premature ejaculation. Curr Opin Investig Drugs 5: 743-747.
40. Waldinger, MD, Zwinderman, AH, Olivier, B. (2001 a) Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J Clin Psychopharmacol 21: 293-297.
41. Waldinger, MD, Zwinderman, AH, Olivier, B. (2001 b) SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram. J Clin Psychopharmacol 21: 556-560.
42. Waldinger, MD, Zwinderman, AH, Olivier, B. (2003) Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol 23: 467-470.
43. Waldinger, MD, Zwinderman, AH, Schweitzer, DH, Olivier, B. (2004) Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 16: 369-381.
44. Zajecka, JM (2000) Clinical issues in long-term treatment with antidepressants. J Clin Psychiatry 61 (Suppl. 2). 20-25.